You are here: Industry Insights > Fosun

News List

Dova Pharma inks distribution pact with Fosun biospectrumasia
March 21, 2018
Fosun Pharma Industrial will support the development of avatrombopag for expanded indications in mainland China and Hong Kong, S.A.R., China.
Shanghai Fosun Forms $50M U.S. JV - With Itself biospace
January 12, 2018
Shanghai Fosun Pharma announced a $50 million US joint venture, a JV that includes two Fosun entities.
Fosun Pharma Unit to Raise $190 Million From New Share Issue biospace
December 22, 2017
Shanghai Fosun Pharmaceutical Group, or Fosun Pharma, said research-and-development unit Shanghai Henlius Biotech will raise $190 million from a new share issue.
Fosun Pharma to buy stake in Shenzhen Hospital biospectrumasia
November 14, 2017
The acquisition will help the group establish a platform that specializes in assisted reproduction services.
Fosun pharma cuts stake to 74 % in Gland Pharma deal biospectrumasia
September 20, 2017
Following the amendment, the deal no longer needs approval from the India Foreign Investment Promotion Board and the Cabinet Committee on Economic Affairs of India
China's Fosun Group acquired 74% stake in Gland Pharma for $1.1 billion pharmafile
September 19, 2017
Fosun has sealed the deal of acquiring 74% of India’s Gland Pharma for $1.1 billion.
Fosun Pharma inks deal with Medidata biospectrumasia
August 24, 2017
Fosun Pharma is implementing Medidata Rave, a unified EDC and CDMS solution for capturing, managing and reporting patient data
India set to block $1.3 bn Gland Pharma-Fosun deal : Report expressbpd
August 02, 2017
The deal was announced last July when Shanghai Fosun agreed to buy an 86 per cent stake in KKR & Co-backed Gland Pharma
FIPB refers Gland Pharma proposal to CCEA for approval financialexpress
April 27, 2017
Gland Pharma is seeking approval for its initial acquisition of up to 86.08 per cent by China-based Shanghai Fosun Pharmaceutical (Group) Company
FIPB Defers Gland Pharma's Acquisition by Chinese Firm firstwordpharma
March 27, 2017
India's Foreign Investment and Promotion Board (FIPB) has delayed a deal by Fosun to purchase Gland Pharmaceuticals for $1.4 billion, as reported Business Standard Friday.

Previous page 1 2 3 Next page